JP Morgan Chase
DTIL icon

JP Morgan Chase’s Precision BioSciences DTIL Stock Holding History

JP Morgan Chase’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43 Hold
8
– – ﹤0.01% 7368
2025
Q4 		$33 Hold
8
– – ﹤0.01% 7273
2025
Q3 		$44 Hold
8
– – ﹤0.01% 7232
2025
Q2 		$34 Hold
8
– – ﹤0.01% 6923
2025
Q1 		$38 Hold
8
– – ﹤0.01% 7028
2024
Q4 		$30 Hold
8
– – ﹤0.01% 7211
2024
Q3 		$72 Hold
8
– – ﹤0.01% 7050
2024
Q2 		$78 Sell
8
-8,508
-100% -$100K ﹤0.01% 6937
2024
Q1 		$115K Buy
8,516
+422
+5% +$5.16K ﹤0.01% 5613
2023
Q4 		$88.6K Sell
8,094
-5,674
-41% -$61.2K ﹤0.01% 5791
2023
Q3 		$141K Sell
13,768
-55,782
-80% -$857K ﹤0.01% 5281
2023
Q2 		$1.1M Sell
69,550
-700
-1% -$16K ﹤0.01% 3992
2023
Q1 		$1.59M Buy
70,250
+17,257
+33% +$569K ﹤0.01% 3700
2022
Q4 		$1.89M Buy
52,993
+648
+1% +$25.6K ﹤0.01% 3600
2022
Q3 		$2.04M Buy
52,345
+22,124
+73% +$1.05M ﹤0.01% 3443
2022
Q2 		$1.45M Buy
30,221
+9
+0% +$528 ﹤0.01% 3816
2022
Q1 		$2.79M Buy
30,212
+5,494
+22% +$746K ﹤0.01% 3488
2021
Q4 		$5.49M Sell
24,718
-5,275
-18% -$1.47M ﹤0.01% 2974
2021
Q3 		$10.4M Buy
29,993
+12,801
+74% +$4.34M ﹤0.01% 2354
2021
Q2 		$6.46M Buy
17,192
+10,436
+154% +$3.13M ﹤0.01% 2826
2021
Q1 		$2.1M Buy
6,756
+2,201
+48% +$771K ﹤0.01% 3697
2020
Q4 		$1.14M Buy
4,555
+1,201
+36% +$294K ﹤0.01% 3867
2020
Q3 		$641K Buy
3,354
+511
+18% +$102K ﹤0.01% 3873
2020
Q2 		$710K Sell
2,843
-5,159
-64% -$1.13M ﹤0.01% 3695
2020
Q1 		$1.45M Buy
8,002
+4,872
+156% +$1.28M ﹤0.01% 3182
2019
Q4 		$1.3M Buy
3,130
+3,030
+3,030% +$952K ﹤0.01% 3672
2019
Q3 		$25K Buy
100
+16
+19% +$5.21K ﹤0.01% 5354
2019
Q2 		$33K Sell
84
-1,249
-94% -$503K ﹤0.01% 5322
2019
Q1 		$718K Buy
+1,333
New +$708K ﹤0.01% 3996

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

JP Morgan Chase's DTIL Position: Q1 2026 in Review

JP Morgan Chase held its Precision BioSciences (DTIL) position steady in Q1 2026 at 8 shares worth $43. The position accounts for ﹤0.01% of the portfolio, ranked #7368.

JP Morgan Chase first reported a position in DTIL in Q1 2019 and has held it in 29 quarters since. The position peaked at $10.4M in Q3 2021. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • JP Morgan Chase held 8 shares of Precision BioSciences worth $43 as of Q1 2026.
  • JP Morgan Chase left its Precision BioSciences share count unchanged in Q1 2026.
  • Precision BioSciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7368 holding.
  • JP Morgan Chase first reported a position in Precision BioSciences in Q1 2019 and has held it in 29 quarters since.
  • JP Morgan Chase's Precision BioSciences position peaked at $10.4M in Q3 2021.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.